Medicure Inc. 将发布 2024 年第三季度财务业绩并宣布一名董事会成员辞职。 Medicure Inc. to release Q3 2024 financial results and announces a board member's resignation.

一家制药公司 " Medicure Inc. " 将在11月26日东部时间上午8:30的电话会议上介绍其 " Q3 2024 " 财务结果。 Medicure Inc., a pharmaceutical company, will present its Q3 2024 financial results on a conference call on November 26 at 8:30 AM Eastern Time. 财务结果将在11月25日市场关闭后提交。 The financial results will be filed after the market closes on November 25. 该公司还宣布董事会成员Kimberly Kramchynsky因个人原因辞职,从11月18日起生效。 The company also announced the resignation of board member Kimberly Kramchynsky, effective November 18, for personal reasons. 药品的重点是通过美国的子公司在美国销售和分销AGGRASTATZ和ZYPITAMAGI等药品。 Medicure focuses on marketing and distributing drugs like AGGRASTAT® and ZYPITAMAG® in the U.S. through its subsidiary.